Document Detail


Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program.
MedLine Citation:
PMID:  21430114     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The optimal feeding (breast milk, formula, or a combination) for infants with cystic fibrosis (CF) is unknown. Recommendations from the CF Foundation are based on limited data.
OBJECTIVE: We compared growth and pulmonary outcomes between breastfed and formula-fed infants through the age of 2 y.
DESIGN: A total of 103 CF infants born in 1994-2006 and diagnosed through newborn screening in Wisconsin were studied. Breastfed infants were classified by the duration of exclusive breastfeeding (ExBF). Exclusive formula-feeding (ExFM) was classified by the formula's caloric density (ie, standard [0.67 kcal/mL (20 kcal/oz) (ExFM20)] throughout infancy or high density [≥0.74 kcal/mL (22 kcal/oz) (ExFM22+)] for some duration of infancy).
RESULTS: Fifty-three infants (51% of infants) were breastfed and 50 infants (49% of infants) were ExFM. In breastfed infants, the duration of ExBF was <1 mo (53% of infants), 1-1.9 mo (21% of infants), 2-3 mo (17% of infants), and 4-9 mo (9% of infants). In ExFM infants, 23 infants (46%) received a formula with a high caloric density; approximately half (n = 13) of the ExFM infants received the formula by 6 mo of age. Proportionately more infants with pancreatic sufficiency (n = 9) were ExBF ≥1 mo (44% of infants), and none of the infants were ExFM22+, compared with infants with meconium ileus (n = 24; 13% of infants were ExBF ≥1 mo, and 38% of infants were ExFM22+) or pancreatic insufficiency (n = 70; 25% of infants were ExBF ≥1 mo, and 20% of infants were ExFM22+) (P = 0.02). In infants with pancreatic insufficiency, weight z scores declined from birth to 6 mo (P < 0.0001) in infants who were ExBF ≥2 mo, and the number of Pseudomonas aeruginosa infections through the age of 2 y was fewer in breastfed than in ExFM infants (P = 0.003) but did not differ by the duration of ExBF.
CONCLUSION: For infants with CF, ExBF <2 mo does not compromise growth and is associated with a respiratory benefit.
Authors:
Sarah A Jadin; Grace S Wu; Zhumin Zhang; Suzanne M Shoff; Benjamin M Tippets; Philip M Farrell; Tami Miller; Michael J Rock; Hara Levy; HuiChuan J Lai
Related Documents :
11126574 - Mastitis in the lactating mink female (mustela vison s.) and the development of "greasy...
2133544 - Mammary glands in male marsupials: i. primordia in neonatal opossums didelphis virginia...
9242614 - The influence of dominance rank on the reproductive success of female chimpanzees.
16365854 - Population demography of northern muriquis (brachyteles hypoxanthus) at the estação b...
18209584 - Intestinal blood loss as an aggravating factor of iron deficiency in infants aged 9 to ...
19424054 - No relation between in-utero exposure to haart and intrauterine growth retardation.
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-03-23
Journal Detail:
Title:  The American journal of clinical nutrition     Volume:  93     ISSN:  1938-3207     ISO Abbreviation:  Am. J. Clin. Nutr.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-21     Completed Date:  2011-07-15     Revised Date:  2013-06-30    
Medline Journal Info:
Nlm Unique ID:  0376027     Medline TA:  Am J Clin Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1038-47     Citation Subset:  AIM; IM    
Affiliation:
Department of Nutritional Sciences, College of Agriculture and Life Sciences, University of Wisconsin, Madison, WI 53706, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Feeding*
Child Development*
Child, Preschool
Cystic Fibrosis / diet therapy*,  immunology,  pathology,  physiopathology*
Exocrine Pancreatic Insufficiency / epidemiology,  etiology
Female
Humans
Infant
Infant Formula*
Infant, Newborn
Longitudinal Studies
Lung / immunology,  microbiology,  pathology*
Male
Mass Screening
Medical Records
Pneumonia / microbiology*
Pseudomonas Infections / epidemiology,  microbiology,  prevention & control
Pseudomonas aeruginosa / isolation & purification
Severity of Illness Index
Time Factors
Wisconsin / epidemiology
Grant Support
ID/Acronym/Agency:
DK34108/DK/NIDDK NIH HHS; R01 DK072126/DK/NIDDK NIH HHS; R01DK72126/DK/NIDDK NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predicting cardiovascular disease risk factors in midadulthood from childhood body mass index: utili...
Next Document:  Diet, vegetarianism, and cataract risk.